New developments in the combination treatment of COPD: focus on umeclidinium/vilanterol

An increasing body of evidence suggests that the long-acting muscarinic antagonist (LAMA)/long-acting β(2)-agonist (LABA) combination appears to play an important role in maximizing bronchodilation, with studies to date indicating that combining different classes of bronchodilators may result in sig...

Descripción completa

Detalles Bibliográficos
Autores principales: Cazzola, Mario, Segreti, Andrea, Matera, Maria Gabriella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797618/
https://www.ncbi.nlm.nih.gov/pubmed/24143077
http://dx.doi.org/10.2147/DDDT.S39449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797618/
https://www.ncbi.nlm.nih.gov/pubmed/24143077
http://dx.doi.org/10.2147/DDDT.S39449

Ejemplares similares